Scientific Programme
THEME : LIVER TRANSPLANT BEYOND BORDERS
Day 1 - 17 November, Friday
Day 2 - 18 November, Saturday
Day 3 - 19 November, Sunday
| HALL A |
| Topics |
| Robotic donor hepatectomy: Tips, Tricks, cost minimisation, future robots |
| Laparoscopic donor hepatectomy: the open procedure is no longer relevant |
| Open donor hepatectomy cannot be ignored |
| Is there a place for hybrid procedures? |
| Impact of minimally invasive donor hepatectomy on biliary complications in recipients and donor |
| Strategies for low remnant volume donors |
| Coffee break |
| Graft Inflow modulation: For |
| Graft Inflow modulation: Against |
| Complex Donor Anatomy |
| Portal vein thrombosis and collaterals |
| Minimally Invasive recipient surgery: Are we there? |
| LUNCH |
| Can we achieve zero mortality after LDLT? |
| Vascular complications after LDLT |
| Optimising outcomes in paediatric liver transplant |
| Early Radiological interventions after LDLT |
| TEA |
| Early retransplant after LDLT |
| Liver biopsy in the first 2 weeks after LDLT |
| LDLT: current and future perspective |
| HALL B (Hepatology) |
| Topics |
| Session 1: Immunosuppression in LT |
| Immunosuppression in different clinical situations |
| Role of biomarkers in rejection post LT |
| Managing pregnancy in liver transplant recipient |
| Session 2: Renal issues in LT |
| Optimizing renal parameters and hyponatremia prior to transplant |
| Early post operative management of a sick recipient |
| Sequential versus combined liver kidney transplant-Is there a consensus? |
| TEA |
| Session 3: Infections in LT |
| Antibiotics stewardship in LT -Less is more? |
| When is infection a contraindication for transplantation? |
| Fungal infections in post LT period -Risk factors and management |
| LUNCH |
| Session 4: Post LT Issues- I |
| Post LT metabolic syndrome |
| Management of diabetes in Pre and Post-transplant period |
| Management of post LT HCC recurrence |
| Session 5: Post LT Issues- II |
| How does one differentiate between Rejection, SFSS, Sepsis in the early post Liver Transplant period |
| Prevention of Post Transplant Hepatitis B reactivation: Evolution from HBIG to NA's to NA withdrawal |
| Role of AI/Machine learning in LT |
| TEA |
| Session 6: Miscellaneous |
| ATT Hepatotoxicity induced Liver failure: Characterization & Algorithmic approach to medical management |
| Malignancy and liver transplant-Guidelines versus practical approach |
| Management - Pre & Post Transplant |
| New potential therapeutic drug targets |
| Outcomes of hepatitis B virus positive grafts |
| Management of chronic hepatitis C infection in children- An update |
| HALL C |
| Topics |
| Pre Lunch Session: Transplant Coordinators Workshop |
| Welcome address |
| Definition and diagnosis of brain stem death |
| Progress in Brain death donation in India |
| Brain death donation- Hurdles and solutions |
| DCD/Non heart beating donation- Potential and feasibility in India |
| TEA |
| Debate- Donor family should be given incentive- for/against |
| Protocols to be followed in Brain death patients who are not donors |
| How to promote deceased organ donation in private hospitals |
| How to overcome the cultural barriers in in deceased organ donation |
| Media and public awareness in organ donation |
| Role of NGOs and religious bodies in deceased organ donation |
| Role of government in promoting organ donation |
| Ethical issues in organ allocation and patient selection |
| Organ referral process- the trick for success |
| Do’s and don’t of councelling for donation - the fine line |
| Multiple listing in various centre- justification and problems faced |
| Should the organ travel for recipient in Indian set up |
| Responsibilities of procurement coordinator in pre, peri and post organ procurement |
| Post Lunch Session |
| Surgical Workshops- (Possibilities-Vascular anastomosis, Parenchymal transection devices, Ultrsound for surgeons, Robotic trainer/ 3 d printing technology/ VR training/ Machine perfusion) |
| Anesthesia workshops-( Possibilities- TEE, TEG, TCD monitoring Regional blocks for donor anesthesia) |
| Hepatology workshop-An approach to liver pathology |
| General body meeting- hall A on Saturday OR Friday – one hour |
| iLDLT Vanguard session: Saturday/Sunday Hall B |
|
HALL A |
|
Topics |
|
Liver Transplant in public Sector |
|
LT In Kazakhstan: impact of collaboration with other Centres |
|
LT in Iran: How we developed both DDLT and LDLT |
|
Panel Discussion: How to start a LDLT program? |
|
Government support for LT |
|
Improving gender imbalance in LDLT in India |
|
Managing patients transplanted abroad |
|
LDLT: Infrastructure First |
|
LDLT: Trained Team First |
|
TEA |
|
Patient Selection |
|
HCC beyond Milan: Where do we stand? |
|
LDLT for ACLF 3 |
|
Futility scores in LDLT |
|
Alcoholic Hepatitis: To transplant or not |
|
LUNCH |
|
LDLT for Hepatorenal Syndrome |
|
Medical contraindications to LDLT |
|
Video Session |
|
Multiple donor ducts |
|
The optimal biliary reconstruction |
|
Anterior sector drainage |
|
Multiple right hepatic veins (Inferior?) |
|
Multiple portal veins |
|
Monosegment graft |
|
Medially reduced graft |
|
Dissected recipient artery |
|
Atretic portal vein in BA |
|
Complete PVT and renoportal jump graft |
|
HALL B (Anesthesia) |
|
Topics |
|
Non heart beating donor- How to increase the donor pool |
|
Fibrinogen concentrate and prothrombin concentrate in LT : Is there any flip side? |
|
Citrate Anticoagulation for CRRT in CLD : Is it safe? |
|
Role of ECMO in Liver recipient |
|
Diastolic Dysfunction: A silent peril - Optimisation & Management |
|
Role of Parenteral Nutrition in patients with liver disease |
|
Assessment of fluid responsiveness- recent updates |
|
Case Discussion: Coronary revascularization before or after LDLT? Dilemma in dCLD patients with history of CAD |
|
Refractory vasoplegia- recent updates |
|
Metabolic Liver disease - Challenges - crisis prevention & management |
|
Massive Transfusion to cell save or not (Pro/ Con) |
|
Total Intravenous Anesthesia in LDLT |
|
Recipients with persisting encephalopathy: Pros and Cons of early tracheostomy after LT |
|
The optimal strategy for managing Rejection and Sepsis in the early postoperative transplant period |
|
PLEX in EGD – what is the evidence? |
|
Need of thromboprophylaxis in LDLT: Specific scenarios/indication |
|
HALL C |
|
Topics |
|
Panel Discussion- Ensuring Gender equality in career opportunities in Liver Transplantation- |
|
Interventional Radiology In cirrhosis |
|
TIPS: indications and late results |
|
Portal vein recanalization |
|
HVOT: Intervention vs Transplant |
|
LTSI Free paper sessions |
|
LTSI on the Pubmed |
|
HALL A |
|
Topics |
|
Session 1: ABOi LT |
|
Desensitization protocols |
|
Postoperative management |
|
Diffuse Ischemic Biliary strictures |
|
State of the Art Lecture: Donor and recipient genetic interaction – thinking beyond the MHC. |
|
Session 2: LT for ALF and ACLF |
|
Plasmapheresis for ALF: does it alter patient selection criteria |
|
ACLF definitions |
|
Reversibility in ACLF |
|
When to transplant in ALF |
|
Session 3: HCC |
|
Liver Resection for major vascular tumor invasion |
|
Current tools for predicting tumor behavior |
|
Downstaging protocols in HCC; |
|
TARE; indications and combinations with systemic therapy |
|
Evolving Strategies in LDLT for Hepatocellular Carcinoma |
|
Lunch |
|
Session 4 |
|
Panel discussion |
|
Developing LT in the public sector- do we really need Pvt hospitals to help? |
|
Ensuring donor safety during the MIS learning curve |
|
Debate |
|
Hub and Spoke Model - Is it the right fit for transplant outside metros? |
|
Session 5: Cadaveric Transplant |
|
How can we improve deceased donor management in India? |
|
Gender imbalance in LDLT in India- Is it real? can we correct it? (patients) – Gomathy Narasimhan |
|
Machine perfusion; How far are we from routine use |
|
Hypothermic Machine Perfusion vs NMP- which strategy works best for India |
|
NOTTO - how far have we come |
|
HALL B (Course: Pediatric Hepatology) |
|
Topics |
|
Timing of liver transplant in children with portal hypertension and mild liver dysfunction |
|
A second chance for “Too sick for transplant” – Is it possible? |
|
Role of creatinine, sarcopenia, and hyponatremia in the listing- Does PELD need modifications? |
|
Metabolic liver disease- When to and when not to transplant? |
|
Discussion |
|
Session 2: Pediatric liver transplant- Specific concerns |
|
Strategies to prevent portal vein thrombosis |
|
Graft volume and outcome |
|
On table extubation- Pros and Cons |
|
Liver transplant for non-hepatoblastoma tumors |
|
Domino liver transplant- Techniques and outcome |
|
Discussion |
|
Session 3: Post-transplant care |
|
Induction immunosuppression therapy- Is it worth it? |
|
Early diagnosis and management of biliary complications |
|
Recurrence of pediatric liver diseases after LT |
|
Monitoring of CMV and EBV post-transplant |
|
Discussion |
|
Session 4: Long-term outcome |
|
Graft fibrosis and long-term survival |
|
Operational tolerance after transplant- A pipe dream |
|
Post-transplant vaccination- Live and Killed |
|
Post-transplant PTLD and other malignancies |
|
Discussion |
THEME : LIVER TRANSPLANT BEYOND BORDERS
Day 1 - 17 November, Friday
Day 2 - 18 November, Saturday
Day 3 - 19 November, Sunday
| HALL A |
| Topics |
| Robotic donor hepatectomy: Tips, Tricks, cost minimisation, future robots |
| Laparoscopic donor hepatectomy: the open procedure is no longer relevant |
| Open donor hepatectomy cannot be ignored |
| Is there a place for hybrid procedures? |
| Impact of minimally invasive donor hepatectomy on biliary complications in recipients and donor |
| Strategies for low remnant volume donors |
| Coffee break |
| Graft Inflow modulation: For |
| Graft Inflow modulation: Against |
| Complex Donor Anatomy |
| Portal vein thrombosis and collaterals |
| Minimally Invasive recipient surgery: Are we there? |
| LUNCH |
| Can we achieve zero mortality after LDLT? |
| Vascular complications after LDLT |
| Optimising outcomes in paediatric liver transplant |
| Early Radiological interventions after LDLT |
| TEA |
| Early retransplant after LDLT |
| Liver biopsy in the first 2 weeks after LDLT |
| LDLT: current and future perspective |
| HALL B (Hepatology) |
| Topics |
| Session 1: Immunosuppression in LT |
| Immunosuppression in different clinical situations |
| Role of biomarkers in rejection post LT |
| Managing pregnancy in liver transplant recipient |
| Session 2: Renal issues in LT |
| Optimizing renal parameters and hyponatremia prior to transplant |
| Early post operative management of a sick recipient |
| Sequential versus combined liver kidney transplant-Is there a consensus? |
| TEA |
| Session 3: Infections in LT |
| Antibiotics stewardship in LT -Less is more? |
| When is infection a contraindication for transplantation? |
| Fungal infections in post LT period -Risk factors and management |
| LUNCH |
| Session 4: Post LT Issues- I |
| Post LT metabolic syndrome |
| Management of diabetes in Pre and Post-transplant period |
| Management of post LT HCC recurrence |
| Session 5: Post LT Issues- II |
| How does one differentiate between Rejection, SFSS, Sepsis in the early post Liver Transplant period |
| Prevention of Post Transplant Hepatitis B reactivation: Evolution from HBIG to NA's to NA withdrawal |
| Role of AI/Machine learning in LT |
| TEA |
| Session 6: Miscellaneous |
| ATT Hepatotoxicity induced Liver failure: Characterization & Algorithmic approach to medical management |
| Malignancy and liver transplant-Guidelines versus practical approach |
| Management - Pre & Post Transplant |
| New potential therapeutic drug targets |
| Outcomes of hepatitis B virus positive grafts |
| Management of chronic hepatitis C infection in children- An update |
| HALL C |
| Topics |
| Pre Lunch Session: Transplant Coordinators Workshop |
| Welcome address |
| Definition and diagnosis of brain stem death |
| Progress in Brain death donation in India |
| Brain death donation- Hurdles and solutions |
| DCD/Non heart beating donation- Potential and feasibility in India |
| TEA |
| Debate- Donor family should be given incentive- for/against |
| Protocols to be followed in Brain death patients who are not donors |
| How to promote deceased organ donation in private hospitals |
| How to overcome the cultural barriers in in deceased organ donation |
| Media and public awareness in organ donation |
| Role of NGOs and religious bodies in deceased organ donation |
| Role of government in promoting organ donation |
| Ethical issues in organ allocation and patient selection |
| Organ referral process- the trick for success |
| Do’s and don’t of councelling for donation - the fine line |
| Multiple listing in various centre- justification and problems faced |
| Should the organ travel for recipient in Indian set up |
| Responsibilities of procurement coordinator in pre, peri and post organ procurement |
| Post Lunch Session |
| Surgical Workshops- (Possibilities-Vascular anastomosis, Parenchymal transection devices, Ultrsound for surgeons, Robotic trainer/ 3 d printing technology/ VR training/ Machine perfusion) |
| Anesthesia workshops-( Possibilities- TEE, TEG, TCD monitoring Regional blocks for donor anesthesia) |
| Hepatology workshop-An approach to liver pathology |
| General body meeting- hall A on Saturday OR Friday – one hour |
| iLDLT Vanguard session: Saturday/Sunday Hall B |
|
HALL A |
|
Topics |
|
Liver Transplant in public Sector |
|
LT In Kazakhstan: impact of collaboration with other Centres |
|
LT in Iran: How we developed both DDLT and LDLT |
|
Panel Discussion: How to start a LDLT program? |
|
Government support for LT |
|
Improving gender imbalance in LDLT in India |
|
Managing patients transplanted abroad |
|
LDLT: Infrastructure First |
|
LDLT: Trained Team First |
|
TEA |
|
Patient Selection |
|
HCC beyond Milan: Where do we stand? |
|
LDLT for ACLF 3 |
|
Futility scores in LDLT |
|
Alcoholic Hepatitis: To transplant or not |
|
LUNCH |
|
LDLT for Hepatorenal Syndrome |
|
Medical contraindications to LDLT |
|
Video Session |
|
Multiple donor ducts |
|
The optimal biliary reconstruction |
|
Anterior sector drainage |
|
Multiple right hepatic veins (Inferior?) |
|
Multiple portal veins |
|
Monosegment graft |
|
Medially reduced graft |
|
Dissected recipient artery |
|
Atretic portal vein in BA |
|
Complete PVT and renoportal jump graft |
|
HALL B (Anesthesia) |
|
Topics |
|
Non heart beating donor- How to increase the donor pool |
|
Fibrinogen concentrate and prothrombin concentrate in LT : Is there any flip side? |
|
Citrate Anticoagulation for CRRT in CLD : Is it safe? |
|
Role of ECMO in Liver recipient |
|
Diastolic Dysfunction: A silent peril - Optimisation & Management |
|
Role of Parenteral Nutrition in patients with liver disease |
|
Assessment of fluid responsiveness- recent updates |
|
Case Discussion: Coronary revascularization before or after LDLT? Dilemma in dCLD patients with history of CAD |
|
Refractory vasoplegia- recent updates |
|
Metabolic Liver disease - Challenges - crisis prevention & management |
|
Massive Transfusion to cell save or not (Pro/ Con) |
|
Total Intravenous Anesthesia in LDLT |
|
Recipients with persisting encephalopathy: Pros and Cons of early tracheostomy after LT |
|
The optimal strategy for managing Rejection and Sepsis in the early postoperative transplant period |
|
PLEX in EGD – what is the evidence? |
|
Need of thromboprophylaxis in LDLT: Specific scenarios/indication |
|
HALL C |
|
Topics |
|
Panel Discussion- Ensuring Gender equality in career opportunities in Liver Transplantation- |
|
Interventional Radiology In cirrhosis |
|
TIPS: indications and late results |
|
Portal vein recanalization |
|
HVOT: Intervention vs Transplant |
|
LTSI Free paper sessions |
|
LTSI on the Pubmed |
|
HALL A |
|
Topics |
|
Session 1: ABOi LT |
|
Desensitization protocols |
|
Postoperative management |
|
Diffuse Ischemic Biliary strictures |
|
State of the Art Lecture: Donor and recipient genetic interaction – thinking beyond the MHC. |
|
Session 2: LT for ALF and ACLF |
|
Plasmapheresis for ALF: does it alter patient selection criteria |
|
ACLF definitions |
|
Reversibility in ACLF |
|
When to transplant in ALF |
|
Session 3: HCC |
|
Liver Resection for major vascular tumor invasion |
|
Current tools for predicting tumor behavior |
|
Downstaging protocols in HCC; |
|
TARE; indications and combinations with systemic therapy |
|
Evolving Strategies in LDLT for Hepatocellular Carcinoma |
|
Lunch |
|
Session 4 |
|
Panel discussion |
|
Developing LT in the public sector- do we really need Pvt hospitals to help? |
|
Ensuring donor safety during the MIS learning curve |
|
Debate |
|
Hub and Spoke Model - Is it the right fit for transplant outside metros? |
|
Session 5: Cadaveric Transplant |
|
How can we improve deceased donor management in India? |
|
Gender imbalance in LDLT in India- Is it real? can we correct it? (patients) – Gomathy Narasimhan |
|
Machine perfusion; How far are we from routine use |
|
Hypothermic Machine Perfusion vs NMP- which strategy works best for India |
|
NOTTO - how far have we come |
|
HALL B (Course: Pediatric Hepatology) |
|
Topics |
|
Timing of liver transplant in children with portal hypertension and mild liver dysfunction |
|
A second chance for “Too sick for transplant” – Is it possible? |
|
Role of creatinine, sarcopenia, and hyponatremia in the listing- Does PELD need modifications? |
|
Metabolic liver disease- When to and when not to transplant? |
|
Discussion |
|
Session 2: Pediatric liver transplant- Specific concerns |
|
Strategies to prevent portal vein thrombosis |
|
Graft volume and outcome |
|
On table extubation- Pros and Cons |
|
Liver transplant for non-hepatoblastoma tumors |
|
Domino liver transplant- Techniques and outcome |
|
Discussion |
|
Session 3: Post-transplant care |
|
Induction immunosuppression therapy- Is it worth it? |
|
Early diagnosis and management of biliary complications |
|
Recurrence of pediatric liver diseases after LT |
|
Monitoring of CMV and EBV post-transplant |
|
Discussion |
|
Session 4: Long-term outcome |
|
Graft fibrosis and long-term survival |
|
Operational tolerance after transplant- A pipe dream |
|
Post-transplant vaccination- Live and Killed |
|
Post-transplant PTLD and other malignancies |
|
Discussion |
